Determinants of survival in idiopathic pulmonary fibrosis - Test2 - elhamkhani - TriplyDB

Determinants of survival in idiopathic pulmonary fibrosis

Determinants of survival in idiopathic pulmonary fibrosis

http://www.wikidata.org/entity/Q23911353

about

mRNA and miRNA regulatory networks reflective of multi-walled carbon nanotube-induced lung inflammatory and fibrotic pathologies in mice Immunomodulatory agents for idiopathic pulmonary fibrosis Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK Anti-cytokine therapy in fibrosing alveolitis: where are we now?IPF: new insight on pathogenesis and treatment An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management Pulmonary (99m)Tc-DTPA aerosol clearance and survival in usual interstitial pneumonia (UIP)Nuclear Factor-Erythroid-2-Related Factor 2 in Aging and Lung Fibrosis Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis Secreted Phosphoprotein 1 and Sex-Specific Differences in Silica-Induced Pulmonary Fibrosis in Mice Targeting the isoprenoid pathway to abrogate progression of pulmonary fibrosis Epidemiology and management of common pulmonary diseases in older persons Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema.Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model.Idiopathic interstitial pneumonias: progress in classification, diagnosis, pathogenesis and management Pulmonary function impairment in patients with combined pulmonary fibrosis and emphysema with and without airflow obstruction.Lung fibrosis.Racial and ethnic disparities in idiopathic pulmonary fibrosis: A UNOS/OPTN database analysis Genetics and early detection in idiopathic pulmonary fibrosis Idiopathic pulmonary fibrosis: Impact of oxygen and colchicine, prednisone, or no therapy on survival.Centrilobular emphysema combined with pulmonary fibrosis results in improved survival.Increased constitutive αSMA and Smad2/3 expression in idiopathic pulmonary fibrosis myofibroblasts is KCa3.1-dependent.Prognostic value of immunohistochemical surfactant protein A expression in regenerative/hyperplastic alveolar epithelial cells in idiopathic interstitial pneumonias Gender-based differences in bleomycin-induced pulmonary fibrosis.Idiopathic pulmonary fibrosis: survival in population based and hospital based cohorts.Raised plasma concentrations of alpha-defensins in patients with idiopathic pulmonary fibrosis.Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatment Cryptogenic fibrosing alveolitis and the fibrosing alveolitis of systemic sclerosis: morphological differences on computed tomographic scans Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis.Idiopathic pulmonary fibrosis: current and future treatment options.Smoking and idiopathic pulmonary fibrosis A functional genomic model for predicting prognosis in idiopathic pulmonary fibrosis.British Thoracic Society Study on cryptogenic fibrosing alveolitis: Response to treatment and survival.Clinical and pathologic features of familial interstitial pneumonia.Idiopathic fibrotic lung disease at a university hospital setting: management and prognostic factors Interferon gamma-1b in the treatment of idiopathic pulmonary fibrosis.Emerging drugs for idiopathic pulmonary fibrosis.WNT7B in fibroblastic foci of idiopathic pulmonary fibrosis Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapy Computed tomography-guided bronchoalveolar lavage in idiopathic pulmonary fibrosis.

P2860

Q23915560-E01F0680-39E4-4544-A163-A8805AAF2E2E Q24248714-78593381-649B-4D7C-925C-2FCF435046C2 Q24670477-D303F6DB-1654-4407-B131-612A12154173 Q24790968-4905C517-96B5-4C30-930A-882D9B4A4355 Q28272013-F2F77543-7B03-420E-ABE4-B40227069C44 Q28308246-8DC9C063-4498-4C46-AC55-7E6012743581 Q28364403-DDF5A889-7FB4-40D5-94A2-7DEAB62A2CCE Q28383171-5C797759-34B1-47DE-8313-F14126E530B2 Q28386047-B2000EAC-1D80-4077-B4A6-9F8AC61A9F57 Q28386089-94AED4B6-1EB3-4856-B33B-E54EDF585FDD Q28387228-F854AD60-982C-46E4-91DC-624A4880BC6A Q28397465-5B3209A1-BFC1-4086-9845-A1183EEE8898 Q33855641-99C94984-F3FB-4210-839E-9D058C0BC27C Q33955628-52DC913C-F626-4082-BEC8-557A0FD08290 Q34000433-B10F17A5-9604-44BE-96DE-151EF332DE4C Q34005618-838359FD-5E2A-4207-8EBA-083A425BA465 Q34005621-873FF2BB-59C2-4FED-8521-3819D675440D Q34129022-3D4EB132-1920-41CA-BB6E-61524CA53EC7 Q34479395-9D9FEB2D-91F8-483F-B6C4-219DCCFB0A10 Q34508187-556C22C2-6AF0-4C1E-832D-7B44C36E67D7 Q34662558-4AFAB2D2-858B-4B12-B576-707A9ABCD739 Q34677065-B2F64CE9-D789-416F-BC96-12DAB7B1A593 Q34769862-00FCA1B2-4F56-4E24-B21A-4984830E0A23 Q35083947-778D1A67-48F2-45F0-B573-635D2993DF56 Q35532508-7F586F9C-79BA-4BCA-9724-AA7FB036262B Q35535282-3814ED86-7209-4912-83F5-8AF1CB5781C0 Q35551942-8CDB83C9-7FB4-4533-955C-81C5ACE08002 Q35563419-34CFEF27-41FF-4789-9136-6019A049177E Q35610196-ECD3CA3D-09DC-4AAF-A2E3-10A2041C65F3 Q35627863-EE74BAA5-427F-4EBA-9543-79B0AE56986C Q35788811-26174BEA-4661-4C38-BF70-E875E291C12D Q35847544-22CC3BFE-A74C-45EB-85B9-E7F5441EB4B1 Q36203281-F73C6591-92D9-4F91-89A9-51E895D67DBB Q36234581-CDA6ECB6-FAE0-4882-A98C-38EF8364E3A3 Q36239398-119B7260-CD21-49B6-9F4A-21ABD0DA9CE9 Q36256282-DFDF944D-63DA-4ACF-A6FD-6483F57C7CF9 Q36302828-33C0D683-7F94-4A02-9C01-499CF2427847 Q36341184-6146DE96-ACD0-4303-ADCC-97934A1C70EB Q36440438-53697AC3-5F49-4E06-A5C4-4AC28E608095 Q36498918-79FAC78E-6BE8-4C06-A269-983760B7A894

P2860

Determinants of survival in idiopathic pulmonary fibrosis

http://www.wikidata.org/entity/Q23911353

description

1994 nî lūn-bûn

@nan

1994 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

1994 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

name

Determinants of survival in idiopathic pulmonary fibrosis

@ast

Determinants of survival in idiopathic pulmonary fibrosis

@en

Determinants of survival in idiopathic pulmonary fibrosis

@en-gb

Determinants of survival in idiopathic pulmonary fibrosis

@nl

type

label

Determinants of survival in idiopathic pulmonary fibrosis

@ast

Determinants of survival in idiopathic pulmonary fibrosis

@en

Determinants of survival in idiopathic pulmonary fibrosis

@en-gb

Determinants of survival in idiopathic pulmonary fibrosis

@nl

prefLabel

Determinants of survival in idiopathic pulmonary fibrosis

@ast

Determinants of survival in idiopathic pulmonary fibrosis

@en

Determinants of survival in idiopathic pulmonary fibrosis

@en-gb

Determinants of survival in idiopathic pulmonary fibrosis

@nl

P1433

Q23911353-64745A57-04B8-4421-B7CF-F77D66B422F8

P1476

Q23911353-F3F263E6-AAEF-47BC-9EE8-D00C751A8BD9

P2093

Q23911353-1A949589-7AD4-4B76-AD5A-F0456F9A5707

Q23911353-2358A3FD-F805-4115-B078-96E88285909D

Q23911353-6AE99A39-4BFC-4A3F-A7A4-DB58F214718B

Q23911353-B74D49B4-0B2C-454E-A222-18A78B453F6E

Q23911353-B8A884A2-533B-44DA-9AC9-607D28C86882

Q23911353-BBF2E519-011C-4043-9961-64C78949AAF0

Q23911353-E270416E-EFAE-4E51-950E-9CE4AC6FDE09

Q23911353-F685E80E-11C3-4E57-A48B-94CB6FD988A0

P2880

Q23911353-D3BA22E5-487D-4702-AD98-9989B4B7712D

P304

Q23911353-6A0747D7-7D12-466B-835C-C970959D943C

P31

Q23911353-B67225B2-3853-4B8C-AD4D-674841C35753

P3181

Q23911353-83EB1DE8-23C5-410D-889C-99899B843255

P356

Q23911353-F18571EC-9D29-4E54-A5A1-2B9A890BCD8B

P407

Q23911353-D8F0F91C-168D-4FC5-8898-BAA8F3B85F8F

P433

Q23911353-E9186278-C50A-49D0-A89B-17F3567732F1

P478

Q23911353-860A3D65-ED15-4FF5-9BD3-388B24F7DCAC

P577

Q23911353-7CE3619C-6B82-4704-BB68-1B2DB44271D8

P698

Q23911353-73ACC55E-5416-46B6-9028-50EAF8D15CD1

P859

Q23911353-87C2FA19-2DEB-4B9B-81AC-B619B58C1EB3

P921

Q23911353-2B01D0D2-DA62-416F-BE4D-EC94F1D88824

Q23911353-6D9659D5-F4AC-44C6-8FB9-9D1AC942B25B

Q23911353-7554FF8B-DAE4-4DB6-A782-8B6B53764C61

Q23911353-A5598DFC-F500-4636-838D-4B97D1911EFE

Q23911353-D36E8A2E-FE96-4DFD-9ED4-E837A5E90964

Q23911353-E39A5200-1340-45C2-8036-5E1D3937F66E

Q23911353-E742FA78-E76A-4109-8B88-21F6B78C25D6

P3181

P356

AJRCCM.149.2.8306044

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Determinants of survival in idiopathic pulmonary fibrosis

@en

P2093

C S Dayton

http://www.w3.org/2001/XMLSchema#string

D A Schwartz

http://www.w3.org/2001/XMLSchema#string

D S Van Fossen

http://www.w3.org/2001/XMLSchema#string

G W Hunninghake

http://www.w3.org/2001/XMLSchema#string

J R Galvin

http://www.w3.org/2001/XMLSchema#string

K L Frees

http://www.w3.org/2001/XMLSchema#string

L F Burmeister

http://www.w3.org/2001/XMLSchema#string

R A Helmers

http://www.w3.org/2001/XMLSchema#string

P2880

20044948

http://www.w3.org/2001/XMLSchema#string

P304

450-454

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1575464

http://www.w3.org/2001/XMLSchema#string

P356

10.1164/AJRCCM.149.2.8306044

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

149

http://www.w3.org/2001/XMLSchema#string

P577

1994-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8306044

http://www.w3.org/2001/XMLSchema#string

P859

National Institute for Occupational Safety and Health

P921

carbon monoxide

pulmonary fibrosis

respiratory disease

occupational lung disease